To identify patients with HF and stratify risks of adverse outcomes, the evaluation of natriuretic peptides (NPs), such as B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP), is recommended in patients with acute MI in the international guidelines [7,8]. Here, NPPB is linked to hydrops fetalis.